EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sodium–Glucose Cotransporter 2-Mediated Glucose Uptake Contributes to Glycogen Accumulation in Clear Cell Renal Cell Carcinoma: Implications for Clear Cell Morphology and Potential Therapeutic Relevance

Yujiro Nagata iD, Ikko Tomisaki, Takuo Matsukawa, Nguyen Thu Quynh iD, Yuto Tsubonuma, Yoshihiro Sugita, Aya Nawata iD, Keiji Kokubu iD, Ryoko Baba iD, Hiroyuki Morimoto, Kohei Ogawa iD, Koichiro Wada und 1 weitere

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27209128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Yujiro Nagata und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu 807-8555, Fukuoka, Japan. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Glucose, Glycogen, Sodium-Glucose Transporter 2. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Society for the Promotion of Science (JSPS) KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clear cell renal cell carcinoma (ccRCC) is characterized by loss of the functional von Hippel–Lindau (VHL) complex and distinctive clear cell morphology associated with intracellular glycogen and lipid accumulation. However, the mechanism underlying glycogen storage remains unclear. This study was conducted to investigate the relationship between SGLT2, a glucose transporter predominantly expressed in proximal tubular epithelial cells; the cell of origin of ccRCC; and clear cell morphology in ccRCC. Using the VHL-null ccRCC cell line KMRC-1, we investigated the effects of the SGLT2 inhibitor dapagliflozin, SGLT2 knockdown, and VHL overexpression on cellular morphology, intracellular glycogen accumulation, and glucose uptake. Immunohistochemical expression of SGLT2, glucose transporter 1, and VHL was evaluated in morphologically heterogeneous ccRCC specimens. Periodic acid–Schiff (PAS) and PAS with diastase staining, together with quantitative image analysis of PAS-stained cells, showed that dapagliflozin treatment, SGLT2 knockdown, and VHL restoration reduced cytoplasmic area and cytoplasmic PAS staining intensity in KMRC-1 cells. In the fluorescent glucose uptake assay, dapagliflozin significantly reduced the fluorescence signal (p < 0.05). In paired intratumoral analyses of six VHL-deficient ccRCC specimens, SGLT2 immunohistochemical scores were significantly higher in clear cell components than in eosinophilic components (p = 0.026), whereas GLUT1 scores did not differ significantly (p = 0.850). These findings suggest that SGLT2-mediated glucose uptake contributes to glycogen accumulation and the glycogen-rich clear cell morphology of VHL-deficient ccRCC. The potential therapeutic relevance of SGLT2 inhibition in ccRCC warrants further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellGlucoseGlycogenSodium-Glucose Transporter 2Kidney NeoplasmsHumansCell Line, TumorSodium-Glucose Transporter 2 InhibitorsGlucosidesBenzhydryl CompoundsVon Hippel-Lindau Tumor Suppressor Protein

Stichwörter der Autor:innen

SGLT2VHLclear cell renal cell carcinomaglucose uptakeglycogenmolecular pathologymorphology

Substanzen

GlucoseGlycogenSodium-Glucose Transporter 2Sodium-Glucose Transporter 2 InhibitorsdapagliflozinGlucosidesBenzhydryl CompoundsVon Hippel-Lindau Tumor Suppressor ProteinSLC5A2 protein, human

Autor:innen und Institutionen

  • Department of Urology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu 807-8555, Fukuoka, Japan.
  • Department of Urology, Shimane University Faculty of Medicine, Izumo 693-8501, Shimane, Japan.
  • Department of Pathology and Oncology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu 807-8555, Fukuoka, Japan.
  • Department of Anatomy, School of Medicine, University of Occupational and Environmental Health, Kitakyushu 807-8555, Fukuoka, Japan.
  • Department of Urology, Kurate Hospital, Kurate 807-1311, Fukuoka, Japan.

ORCID-Profile: Yujiro Nagata, Nguyen Thu Quynh, Aya Nawata, Keiji Kokubu, Ryoko Baba, Kohei Ogawa, Naohiro Fujimoto

Förderung

  • Japan Society for the Promotion of Science
  • Japan Society for the Promotion of Science (JSPS) KAKENHI

Zitieren

APA

Nagata, Y., Tomisaki, I., Matsukawa, T., Quynh, N. T., Tsubonuma, Y., Sugita, Y., Nawata, A., Kokubu, K., Baba, R., Morimoto, H., Ogawa, K., Wada, K., & Fujimoto, N. (2026). Sodium–Glucose Cotransporter 2-Mediated Glucose Uptake Contributes to Glycogen Accumulation in Clear Cell Renal Cell Carcinoma: Implications for Clear Cell Morphology and Potential Therapeutic Relevance. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27209128

Vancouver

Nagata Y, Tomisaki I, Matsukawa T, Quynh NT, Tsubonuma Y, Sugita Y, et al. Sodium–Glucose Cotransporter 2-Mediated Glucose Uptake Contributes to Glycogen Accumulation in Clear Cell Renal Cell Carcinoma: Implications for Clear Cell Morphology and Potential Therapeutic Relevance. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27209128

BibTeX
@article{Nagata2026,
  author = {Nagata, Yujiro and Tomisaki, Ikko and Matsukawa, Takuo and Quynh, Nguyen Thu and Tsubonuma, Yuto and Sugita, Yoshihiro and Nawata, Aya and Kokubu, Keiji and Baba, Ryoko and Morimoto, Hiroyuki and Ogawa, Kohei and Wada, Koichiro and Fujimoto, Naohiro},
  title = {Sodium–Glucose Cotransporter 2-Mediated Glucose Uptake Contributes to Glycogen Accumulation in Clear Cell Renal Cell Carcinoma: Implications for Clear Cell Morphology and Potential Therapeutic Relevance},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27209128}
}
Kostenlos starten →